Friday, May 29th, 2020.
NASA announced their selection of manufacturers for a new ventilator, including iButtonLink in Whitewater, WI.
After receiving more than 100 applications, NASA’s Jet Propulsion Laboratory (JPL) in Southern California has selected eight U.S. manufacturers to make a new ventilator tailored for coronavirus (COVID-19) patients.
Called VITAL (Ventilator Intervention Technology Accessible Locally), the high-pressure ventilator was designed to use one-seventh the parts of a traditional ventilator, relying on parts already available in supply chains. It offers a simpler, more affordable option for treating critical patients while freeing up traditional ventilators for those with the most severe COVID-19 symptoms. Its flexible design means it also can be modified for use in field hospitals.
The Office of Technology Transfer and Corporate Partnerships at Caltech, which owns the patents and software for VITAL, is offering a free license for the device. Caltech manages JPL for NASA.
The U.S. companies selected for licenses are:
- Vacumed, a division of Vacumetrics, Inc. in Ventura, California
- Stark Industries, LLC in Columbus, Ohio
- MVent, LLC, a division of Minnetronix Medical, in St. Paul, Minnesota
- iButtonLink, LLC in Whitewater, Wisconsin
- Evo Design, LLC in Watertown, Connecticut
- DesignPlex Biomedical, LLC in Fort Worth, Texas
- ATRON Group, LLC in Dallas
- Pro-Dex, Inc. in Irvine, California
“The VITAL team is very excited to see their technology licensed. Our hope is to have this technology reach across the world and provide an additional source of solutions to deal with the on-going COVID-19 crisis.”
Leon Alkalai, manager of the JPL Office of Strategic Partnerships and a member of the VITAL leadership team.
See the new ventilator here: https://www.nasa.gov/press-release/eight-us-manufacturers-selected-to-make-nasa-covid-19-ventilator.
Contact WMEP Manufacturing Solutions today for a free initial consultation regarding recovery efforts from the economic crisis and for help dealing with Covid-19 issues.